Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118939 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2020-06-25 | 2020-09-25 | 118942 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118945 |
| TEVA-TOPILENE | 0.05% | OINTMENT | Resolved | 2020-06-25 | 2020-10-01 | 118948 |
| TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118951 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118954 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-06-25 | 2021-02-18 | 118957 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-25 | 2021-04-29 | 118960 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-07-09 | 2021-02-05 | 119877 |
| TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2020-07-09 | 2020-09-10 | 119880 |
| TEVA-PERINDOPRIL | 8MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119883 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2020-07-09 | 2020-10-30 | 119886 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-09 | 2020-08-27 | 119889 |
| TEVA-DONEPEZIL | 5MG | TABLET | Resolved | 2020-07-09 | 2021-04-21 | 119892 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-07-09 | 2020-09-03 | 119895 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119898 |
| ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-09 | 2023-04-28 | 119901 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-09 | 2023-04-28 | 119904 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-07-10 | 2021-01-14 | 119956 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120229 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |